Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 2607679, 6 pages
https://doi.org/10.1155/2018/2607679
Research Article

Effects of Melatonin on Intestinal Microbiota and Oxidative Stress in Colitis Mice

College of Bioscience and Biotechnology, College of Animal Science and Technology, Hunan Agricultural University, Changsha, Hunan 410128, China

Correspondence should be addressed to Hongmei Jiang; nc.ude.uanuh@ncdnmhj and Jun Fang; nc.ude.uanuh@3791nujgnaf

Received 14 October 2017; Revised 29 December 2017; Accepted 4 January 2018; Published 6 February 2018

Academic Editor: Lidong Zhai

Copyright © 2018 Dan Zhu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. T. Dolan and E. B. Chang, “Diet, gut microbes, and the pathogenesis of inflammatory bowel diseases,” Molecular Nutrition & Food Research, vol. 61, no. 1, Article ID 1600129, 2017. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Jostins, S. Ripke, and R. K. Weersma, “Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease,” Nature, vol. 491, no. 7422, pp. 119–124, 2012. View at Publisher · View at Google Scholar
  3. C. Huang, T. Haritunians, D. T. Okou et al., “Characterization of Genetic Loci That Affect Susceptibility to Inflammatory Bowel Diseases in African Americans,” Gastroenterology, vol. 149, no. 6, pp. 1575–86, 2015. View at Google Scholar
  4. J. Z. Liu, S. van Sommeren, H. Huang et al., “Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations,” Nature Genetics, vol. 47, no. 9, pp. 979–986, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. A. N. Ananthakrishnan, “Environmental risk factors for inflammatory bowel disease,” Journal of Gastroenterology and Hepatology, vol. 9, no. 6, pp. 367–374, 2013. View at Google Scholar · View at Scopus
  6. A. D. Kostic, R. J. Xavier, and D. Gevers, “The microbiome in inflammatory bowel disease: current status and the future ahead,” Gastroenterology, vol. 146, no. 6, pp. 1489–1499, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. G. D. Wu, F. D. Bushmanc, and J. D. Lewis, “Diet, the human gut microbiota, and IBD,” Anaerobe, vol. 24, pp. 117–120, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Sánchez, A. C. Calpena, and B. Clares, “Evaluating the oxidative stress in inflammation: role of melatonin,” International Journal of Molecular Sciences, vol. 16, no. 8, pp. 16981–17004, 2015. View at Publisher · View at Google Scholar
  9. A. Bhattacharyya, R. Chattopadhyay, S. Mitra, and S. E. Crowe, “Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases,” Physiological Reviews, vol. 94, no. 2, pp. 329–354, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. J. H. Stehle, A. Saade, O. Rawashdeh et al., “A survey of molecular details in the human pineal gland in the light of phylogeny, structure, function and chronobiological diseases,” Journal of Pineal Research, vol. 51, no. 1, pp. 17–43, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Hardeland, “Melatonin signaling in T cells: Functions and applications,” Journal of Pineal Research, vol. 62, no. 3, 2017. View at Google Scholar
  12. W. Ren, P. Wang, J. Yan et al., “Melatonin alleviates weanling stress in mice: Involvement of intestinal microbiota,” Journal of Pineal Research, p. e12448. View at Publisher · View at Google Scholar
  13. O. M. Tork, S. N. Amin, and L. A. Rashed, “Melatonin Reduces Cardiac Injury Induced by Lipopolysaccharides in Rats,” 2014.
  14. H. H. Hagar, A. El Medany, E. El Eter, and M. Arafa, “Ameliorative effect of pyrrolidinedithiocarbamate on acetic acid-induced colitis in rats,” European Journal of Pharmacology, vol. 554, no. 1, pp. 69–77, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Mazzon, E. Esposito, C. Crisafulli et al., “Melatonin modulates signal transduction pathways and apoptosis in experimental colitis,” Journal of Pineal Research, vol. 41, no. 4, pp. 363–373, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Verma, O. Hashim, J. Jayapalan, and P. Subramanian, “Effect of melatonin on antioxidant status and circadian activity rhythm during hepatocarcinogenesis in mice,” Journal of Cancer Research and Therapeutics, vol. 10, no. 4, pp. 1040–1044, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Gurer-Orhan, C. Karaaslan, S. Ozcan et al., “Novel indole-based melatonin analogues: Evaluation of antioxidant activity and protective effect against amyloid β-induced damage,” Bioorganic & Medicinal Chemistry, vol. 24, no. 8, pp. 1658–1664, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Dragicevic, N. Copes, G. O'Neal-Moffitt et al., “Melatonin treatment restores mitochondrial function in Alzheimer's mice: a mitochondrial protective role of melatonin membrane receptor signaling,” Journal of Pineal Research, vol. 51, no. 1, pp. 75–86, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Re, N. Pellegrini, A. Proteggente, A. Pannala, M. Yang, and C. Rice-Evans, “Antioxidant activity applying an improved ABTS radical cation decolorization assay,” Free Radical Biology & Medicine, vol. 26, no. 9-10, pp. 1231–1237, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. K. R. Amato, C. J. Yeoman, A. Kent et al., “Habitat degradation impacts black howler monkey (Alouatta pigra) gastrointestinal microbiomes,” The ISME Journal, vol. 7, no. 7, pp. 1344–1353, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. J. P. van de Merwe and J. H. Stegeman, “Binding of Coprococcus comes to the Fc portion of IgG. A possible role in the pathogenesis of Crohn's disease?” European Journal of Immunology, vol. 15, no. 8, pp. 860–863, 1985. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Helgeland and P. Brandtzaeg, “Development and function of intestinal B and T cells,” Microbial Ecology in Health and Disease, vol. 12, no. 2, pp. 110–127, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. W. E. C. Moore and L. V. Holdeman, “Human fecal flora: the normal flora of 20 Japanese Hawaiians,” Journal of Applied Microbiology, vol. 27, no. 5, pp. 961–979, 1974. View at Google Scholar · View at Scopus
  24. M. L. Santoru, C. Piras, A. Murgia et al., “Cross sectional evaluation of the gut-microbiome metabolome axis in an Italian cohort of IBD patients,” Scientific Reports, vol. 7, no. 1, article no. 9523, 2017. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Ouwehand, E. Isolauri, and S. Salminen, “The role of the intestinal microflora for the development of the immune system in early childhood,” European Journal of Nutrition, vol. 41, supplement 1, pp. I32–I37, 2002. View at Google Scholar · View at Scopus
  26. M. Matijašić, T. Meštrović, M. Perić et al., “Modulating composition and metabolic activity of the gut microbiota in IBD patients,” International Journal of Molecular Sciences, vol. 17, no. 4, article no. 578, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Loh and M. Blaut, “Role of commensal gut bacteria in inflammatory bowel diseases,” Gut Microbes, vol. 3, no. 6, pp. 544–555, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. U. Gophna, K. Sommerfeld, S. Gophna, W. F. Doolittle, and S. J. O. Veldhuyzen Van Zanten, “Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis,” Journal of Clinical Microbiology, vol. 44, no. 11, pp. 4136–4141, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. J. P. Van de Merwe, P. I. M. Schmitz, and F. Wensinck, “Antibodies to Eubacterium and Peptostreptococcus species and the estimated probability of Crohn's disease,” Epidemiology & Infection, vol. 87, no. 1, pp. 25–33, 1981. View at Publisher · View at Google Scholar · View at Scopus
  30. A. D. Tyler, R. Kirsch, R. Milgrom, J. M. Stempak, B. Kabakchiev, and M. S. Silverberg, “Microbiome heterogeneity characterizing intestinal tissue and inflammatory bowel disease phenotype,” Inflammatory Bowel Diseases, vol. 22, no. 4, pp. 807–816, 2016. View at Publisher · View at Google Scholar · View at Scopus
  31. D. N. Seril, J. Liao, G. Y. Yang, and C. S. Yang, “Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models,” Carcinogenesis, vol. 24, no. 3, pp. 353–362, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. B. J. Dull, K. Salata, A. Van Langenhove, and P. Goldman, “5-Aminosalicylate: Oxidation by activated leukocytes and protection of cultured cells from oxidative damage,” Biochemical Pharmacology, vol. 36, no. 15, pp. 2467–2472, 1987. View at Publisher · View at Google Scholar · View at Scopus
  33. I. Antolín, B. Obst, S. Burkhardt, and R. Hardeland, “Antioxidative protection in a high-melatonin organism: The dinoflagellate Gonyaulax polyedra is rescued from lethal oxidative stress by strongly elevated, but physiologically possible concentrations of melatonin,” Journal of Pineal Research, vol. 23, no. 4, pp. 182–190, 1997. View at Publisher · View at Google Scholar · View at Scopus
  34. P. T. Pentney and G. A. Bubenik, “Melatonin reduces the severity of dextran‐induced colitis in mice,” Journal of Pineal Research, vol. 19, no. 1, pp. 31–39, 1995. View at Publisher · View at Google Scholar · View at Scopus